Apollon Papadimitriou
Vorstandsvorsitzender bei iOmx Therapeutics AG
Profil
Apollon Papadimitriou is currently the Chief Executive Officer at iOmx Therapeutics AG.
He started this position in 2019.
Prior to his current role, he obtained a doctorate degree from Julius-Maximilians-Universität Würzburg in 1995.
Aktive Positionen von Apollon Papadimitriou
| Unternehmen | Position | Beginn |
|---|---|---|
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Vorstandsvorsitzender | 01.07.2019 |
Ausbildung von Apollon Papadimitriou
| Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Health Technology |
